Joycelyn Cornthwaite (US): JoyCare – Right Data, Right Time, Right Recommendations, for better maternal and fetal outcomes

“JoyCare provides a fast, efficient, and easy to implement digitalization of the care process. Alerts support communications to clinicians and patients using existing methods such as EHR messaging, voice calls, and smartphone push. Data-driven escalation procedures along with tracking and auditing help to coordinate resources towards efficient and effective diabetes management.”

Leonard Rinser (GER): GLAICE – Empowering Exercise in Diabetes

“Our digital solution is based on an algorithm that transforms medical research into accessible and easy-to-understand recommendations that are adjusted to the daily lifestyle and tailored to each person’s metabolism. Through this data- and evidence-based approach, GLAICE empowers informed decision-making for everyone with diabetes, supporting you to lead a healthy, active, and self-determined life – anytime, anywhere, and with more ease.”

Jazz Sethi (IN): Back to Basics – A 360 Degree Education Program for Type 1 Diabetes

“India’s healthcare system is overburdened. To combat this, we launched our flagship education project for 1:1 counselling called BACK-TO-BASICS (B2B). Any individual living with T1D or an immediate stakeholder (caregiver, friends & family etc.) can virtually meet with our team of facilitators to navigate daily management, discuss unconventional topics and walkthrough our educational resources. We provide unlimited B2B sessions at no charge, in 9+ languages with a qualified professional, also living with T1D.”

Mridula Kapil Bhargava (IN): CareOll – The Ultimate Patient Advocacy Platform where every voice matters

“An innovative platform that gives voice to Lived experiences of People with Diabetes (and other medical conditions) to facilitate advocacy, qualitative research, first-of-its-kind health education through stories using graphics and animojis with verified disease-related content by experts and patient advocates, and Health-content Checker from social media & messaging platforms.”

Jock Schulz (GER): Welshare Health – Take back control of your health data!

“Take back control of your health data! We are building a tool for you to personalize how you share your health information. That way you can control who has access to it. Whether you get sick while traveling and want to share a certain part of your health record with a doctor or if you want to contribute to medical research- you deserve to choose how your own data is shared. And if you’re interested, you can even monetize your contribution to earn your share.”

Katharine Kelly (UK): Spotlight-AQ − Improving Routine Diabetes Visits: Helping People with Diabetes Feel Heard and Doctors Feel Empowered to Care

“Spotlight-AQ is a novel validated infographic assessment platform highlighting user priority concerns and immediate mapped resources to meet those unmet needs. Truly personalised healthcare. Deliverable by any healthcare professional, in any setting with any person with diabetes; Spotlight-AQ fits seamlessly within the constraints of existing healthcare systems and structures.”

Rob Howe (US): The Diabetes Creator Collective from Diabetics Doing Things

“Founded in 2015, Diabetics Doing Things empowers, informs and inspires people and creators living with diabetes through storytelling, events and community. The Diabetes Creator Collective will create a sustainable ecosystem for creators with diabetes to grow diabetes awareness, fight diabetes stigma and provide a chance for more creators with diabetes to earn a living doing what they do best.”

Stephane Alberth (CH): Aixa – Your Digital Diabetes Guide and Coach

“Enter “Aixa”, your Digital Diabetes Expert Coach. Aixa can provide support along the entire patient journey with a friendly face and warm supportive conversation. In summary, Aixa can integrate the best knowledge and understanding of patient needs to create natural, delightful patient conversations that support them when they need it most, while reducing the workload on the limited available health practitioners.”

Bridget McNulty (SA): Solving diabetes education in Africa, using WhatsApp

“Sweet Life has been creating easy-to-understand diabetes information for our community since we started in 2011, but over the past 3 years we’ve had a specific focus on testing out the most effective formats, language and languages (SA has 11 official languages). We now know how to solve diabetes education in South Africa and pave the way for it to be solved in Africa if we build the system in the right way. How? A WhatsApp chatbot.”

Sam Royston (US):  Replica Health – A Search Engine & Conversational AI for T1D Data

“We build an AI powered search engine for your metabolism, starting with an iOS app that allows diabetics to access their metabolic history to quickly answer questions relevant to their care. We’re working on a system that allows patients (and doctors) to ask detailed questions in plain English. Users receive answers directly via Large Language Models that infer what the user wants and triggers a corresponding analysis of data streams generated by medical devices and smartphones.”

Susa Horvath (GER): ZenZen –  Empower Mothers, Nurture Future

“The innovation of our product is to provide medical knowledge transfer with the help of a digital product to offer 24/7 available medical and emotional support to pregnant women with GDM. With the help of Generative AI technology, we can offer continuous support beyond the scope of traditional medical professional/patient relationships, addressing the full complexity of GDM, including areas such as mental health, exercise, and sleep.”

Greg Badros (US): Gluroo – Collaborative Diabetes Logger

“You already know how to use Gluroo: it’s a chat app! The messaging group is your GluCrew, and Gluroo provides high-quality integrations with CGMs (Dexcom, Libre, and also anything that writes CGM values into Apple HealthKit or Nightscout) and Pumps (DIY Loop, Omnipod 5, and also anything that writes into Apple HealthKit or Nightscout). Those integrations contribute to Gluroo’s diabetes Event Log – the GEL.  That GEL is shared and synchronized in real-time across all the devices so everyone can stay in sync, in real-time.”

Alejandro Clarós (ES): Using the power of AI to Predict and Prevent Metabolic Syndrome and its Comorbidities

“Higia’s AI solutions provide personalized healthcare by analyzing patient data from multiple sources to identify individual risk factors and predict the likelihood of developing certain conditions. This enables patients and healthcare professionals to take proactive measures to prevent or manage chronic diseases by providing tailored recommendations and intervention opportunities.”

Gayathri Badrinath (US): Devyn – Simplifying Life with Gestational Diabetes

“We have developed a first-of-its kind mobile app for GDM that drastically simplifies the patient experience associated with daily self-monitoring during pregnancy and keeps women  in control of their care journey. Our early results are exceptional with extremely high engagement rates.  After pregnancy, we aim to connect our users with medical experts in women’s cardiometabolic health through a virtual visit.”

Leo Rifkind (UK): Huddle Health – Achieving Improved Diabetes Health Outcomes by Evidence-Based Mental Health Therapy

“Huddle Health will be a mobile application that facilitates improved physical health outcomes in diabetes via mental health strategies. It will have a desktop dashboard for Huddle Health administration and Providers to track their patients and carry out appointments.”

Matt Payne (US): No More “Ozempic Butt” – Metabolic Lifestyle Therapy For GLP-1

“Our idea is to complement diabetes and obesity medications like Ozempic and Wegovy with a metabolic support program delivered digitally.”

Jayne Budd (UK): Know your risk of CKD with CSP!

“The CKD Screening Prioritizer (CSP) is digital software that contains an intelligent risk calculator. The healthcare professional can access it via our web portal, or it can be integrated into electronic medical records systems.  It is designed to support targeted Chronic Kidney Disease (CKD) screening (eGFR diagnosis) stratifying the patients by risk so that those most at risk are sent for diagnosis allowing for more efficient resource allocation.”

Elena Paraschiv (RO): Glyco – Your Path to Optimal Diabetes Wellness

“Introducing Glyco, the innovative diabetes management app that’s changing the game. Our app offers a comprehensive solution that goes beyond traditional diabetes management tools, providing users with personalized recommendations, nutrition management, mental health support, complication screening telemedicine, and more. Our cutting-edge app integrates a suite of features that make it easy for users to manage their blood glucose levels, stay on top of their nutrition, connect with medical professionals when needed and support networks.”

Robert Maurer (US): The right drug for the right patient – enabling delivery of standard of care drug selection in routine practice

“We have developed a commercially available analytical report, based on our living expert system reporting platform, which provides physicians with guidance to aid in choosing the optimal treatment regimen for diabetes patients. In addition to glucose control, the TIGAR™ report incorporates insulin resistance, beta-cell condition, cardiovascular disease and kidney condition, all of which impact diabetes care. The result of this personalized therapy is that everyone wins in the first year– doctor, patient, payer, and lab.”

Inka Benthin (GER): GlucoFit – Digital assistant for optimizing insulin therapy

“Introducing GlucoFit, the blood sugar management navigation system that provides automatic and timely information, to free individuals from constantly thinking about their diabetes. By intelligently integrating existing data, GlucoFitidentifies the causes of recurring highs and lows in blood sugar levels and derives actionable advice about therapy adjustments. With a patient-centered approach, this innovative application strengthens therapy adherence and promotes long-term health.”

Derek Brandt
DCB, CEO

Strong Pharma-, Biotech and Medical Device know-how, T1D for the past 35 years. Derek’s mentoring focus is on vision, strategy, positioning & R&D of medical devices.

Maren Schinz
DCB, Innovation Manager

Ph.D. in molecular medicine, T1D for more than 15 years, patient entrepreneur. Specialized in product launches, branding strategies, co-creation and patient networks.

Greta Ehlers
DCB, Business Scout

T1D for 20 years. Strong connection & insights into the user perspective/patient community and strong experience in digital communication, branding and marketing.

Simon Schwaighofer
DCB, Business Development

Medical device launches in start-ups/scale-ups – from late prototype stage to launch plan; business development and B2C/B2B sales.

Stefanie Hossmann
DCB, Clinical Research Scientist

Background in neurobiology, strong experience in clinical evaluation planning and conduct, regulatory affairs and quality managment.

Martina Rothenbühler
DCB, Project Leader Data Sciences

Strong experience in clinical development, trial design, clinical evaluation for health authorities (MDR, FDA) and clinical validation of machine-learning algorithms.

Stefanie Hofer
DCB, Clinical Research Physician

Medical Doctor, Diabetes Specialist and T1D. Stefanie’s mentoring focus lies in Clinical Research, Clinical Trial Strategy and reaching target patients & HCPs.

Cordelia Trümpy
DCB, Innovation & Communication

Business economist and nutrition specialist with more than 20 years of experience in the HealthTech market, at the intersection between science, technology and customer/patient.

Myriam Tinner
DCB, Product Manager

Background in Marketing, several years of experience in medical device product development, requirements definition, validation and global roll-outs and launches.

Ema Grabenweger
DCB, Innovation Manager

M.A. in Business Consultancy Int., 10+ years in MedTech industry corporates & start-ups, go-to-market strategies, regulatory affairs, product launch ex-cellence, global marketing.

Michael Schoemaker
Medical Devices Industry Expert

20+ years experience in MD industry on development of CGM devices, covering all aspects from early research to manufacturing, clinical studies and launch activities.

Valentin Splett
Life Sciences Innovation Consultant

13+ years experience in consulting in life sciences innovation. Valentin’s mentoring focus lies on commercialisation, reimburse-ment, sales, business model and funding.

Paul Senn
Pharma & MedTech Consultant

Pharma and MedTech Consultant. In the industry for 30 years. Strong experience in developing and launching drug products, drug/device combinations and devices in major markets.

George Stark
MedTech Specialist

MedTech specialist, sales manager and business developer for insulin pump and CGM technology. T1D for 14 years, specialized in team management, strategic goal planning & sales effectiveness.

Aurelie Moser
Life Sciences Innovation Consultant

Deep expertise in business model, commercial, access & pricing strategy. Enabling start-ups to reduce time between technology or idea discovery & significant investments or first paying customers.

Walter Esser
Strategy Consultant & Coach

Founder of EuSoftSkills, T1D Dad, Mentor & Trainer. Specialising in Vision, Strategy, Positioning, People & Team, Decision Making and Pitch Optimisation. 

Sabine Nieba
Regulatory Expert

20 years experience in medical device and software, IVD and regulatory affairs quality management. Supporting start-ups in implementing regulatory strategies, QMS and writing submission dossiers.

Lee Leichter
Medical Device & Pharma Consultant

50 years experience in health care industry; 30 years consulting business, scientific, regulatory and quality issues relating to drug delivery & combination products for marketing in the USA/EU/CAN.

Mark Duman
Market Access & Patient Engagement

30+ years experience in combining a management consultant, clinical, & patient background; supporting organisations in market access, patient engagement & digital therapeutics.

Sanjay Gohil
Market Access 

20+ years in diabetes in Pharma, MedTech & Digital health industry working with start-ups/SMEs. Utilising experience, & network to enable market access to improve system and patient outcomes.

Heinz Müller
Patent Expert

20+ years as patent expert at Swiss Federal Institute of Intellectual Property; regular lecturer in biochemistry (University of Basel) and intellectual property law at several Swiss universities.

Hanna Boëthius
Community & Diabetes Expert

T1D for 38 years, international speaker, patient leader, consultant and mentor with a MSc in Diabetes.

Hanne Ballhausen
Project & Community Expert

6+ years project management experience in NGO, science and research, healthcare, communication and media. Project manager of the OPEN project.

Laura Burlando
Community & Diabetes Expert

Patient Advocate, living with type 1 diabetes, deeply involved in the Diabetes Online Community, and passionate about co-creation and representation of the patient voice at every step.

Leon Tribe
Technology & Diabetes Expert

Technology Solutions Advisor & diabetes blogger/researcher. T1D for 6+ years, first class honours degree in quantum physics, MBA in strategy and leadership; participant of the DCB Innovation Challenge 22.

Eduardo W. Jørgensen (ES): Medicsen – Needle and cannula-free Smartpatch for painless insulin delivery based on ultrasounds

“Our wearable SMARTPATCH is the first truly non-invasive delivery patch for large molecules, completely free of needles & cannulas. It ́s based on a patented ultrasonic system that transforms electric currents into sound vibrations to open skin pores temporarily and deliver macromolecular drugs through them.”

Hélène Lefebvre (FR) : Eclypia – Non-Invasive continuous glucose monitoring

“Eclypia is developing a unique non-invasive sensing platform targeting health and wellness. Its first product is a non-invasive Continuous Glucose Monitoring device built on outstanding new and disruptive photonics technologies. At Eclypia, we are driven by excellence and a multi-expertise global approach to tackle technological, physiological and algorithmic challenges.”

Nevena Paunović (CH): OctoPatch − Painless alternative for type 2 diabetes patients depending on injectable drugs

“OctoPatchTM − a small buccal patch that can be easily self-applied to the inner side of the cheek. It gently stretches the mucosa and together with proper additives temporarily permeates the barrier, enabling these large drugs to reach the bloodstream. Our device is not only more attractive than injectors, but it also provides more flexibility regarding intake instructions.”

Ebba Reinholdt (SE): D-stract – Creating painless injections

“D-stract aims to reduce the fear of needles and injections by reducing the pain from the initial injection. Needle phobia is one of the top 5 phobias in the world. Many who have repeated injections, such as people with diabetes, develop needle phobia over time. By using a method that is clinically proven, our product reduces the pain instantly as the product is in contact with your skin.”

Adam Graybill (US): Journey Biosciences is dedicated to creating technologies to predict and overcome preventable diseases

“Journey Biosciences launched the first predictive screening for people with diabetes that identifies patients at risk of chronic kidney disease prior to any clinical signs or symptoms. The company’s target audience and TAM creates strategic synergies in the Laboratory, Pharma, Retail Pharmacy and other Healthcare businesses that value access to newly-diagnosed diabetes patients or identifying at-risk populations of a costly condition.”

Amin Zayani (US/GER): dotcool box – Connected storage container for insulin and biologic injections

“Introducing dotcool box, a connected storage container for medications. With dotcool box, PwD can be assured that their medications are always kept at the correct temperature, protected from accidental freezing and from heating up. Users place their medications inside the box, connect it to their home network and place it inside their refrigerator. It connects it to the dotcool App on their phone and provides real-time remote monitoring.”

Arvind Jina (US):  ArKal Medical – Novel Surface Continuous Glucose Monitoring Technology

“Developing continuous glucose monitoring system for the management of diabetes. ArKal’s monitoring system is designed to eliminate many of the inconveniences of current glucose monitoring technologies. ArKal Medical’s technology has the potential to make an important advancement.”

Olesja Bondarenko (EE): Next-generation nanotechnology to cure diabetic foot ulcers that cannot be cured with standard methods

“We are scientists and medical doctors, who developed platform nanotechnology to prevent and cure topical bacterial infections, including those caused by antibiotic-resistant bacteria. We developed our first product for infected diabetic foot ulcers, an advanced antibacterial wound dressing and tested it in vitro, in animals, and initiated a controlled single-blind randomized clinical trial at the largest Estonian hospital.”

Belén Odriozola (ES): NERVECHECK MASTER – To Increase the diagnoses, to Generate Data and to Personalize medical treatment (diabetic foot)

“An unmet care need has been detected in the diagnostic field of Sensory Neuropathy. There is a lack of effective tools for the diagnosis and control of the indiscriminate evolution of Sensory Neuropathy (Diabetic Foot). Phi Med Europe has developed NerveCheck Quantitative Sensory Testing (QST) equipment, for the quantification and diagnosis of the state of small and long nerve fibres first altered in Diabetic Foot, by running 4 tests: vibration, cold, warm and heat pain.”

Amin Zayani (US/GER): dotcool mini– Wireless temperature sensor for insulin and biologic injections

“Introducing dotcool mini, a wireless temperature sensor for medications. With dotcool mini, PwD can be assured that their medications are always kept at the correct temperature. The user simply places the sensor alongside their medications and connects it to the dotcool App on their phone via Bluetooth.”

Severine Sigrist (FR): MailPan – encapsulation on insulin secreting cell to forget diabetes

“Defymed developed MailPan®, a macro encapsulation device: it has the three pre-requisite functions of protecting the recipient of the injected cells, protecting the donor cells (immune-protection) and maximizing cell function. In addition, the developed device contains enough cells to restore the insulin independence of patients and can be emptied/refilled into cells without additional surgery. Finally, completely implantable, MailPan® is invisible and will therefore allow a physiological treatment of the disease.”

Robert Wylie (UK): Fada Medical – 30-day insulin delivery technology

“We are proud to unveil our new technology that we have developed that can extend an infusion set cannula’s performance for up to 30 days to support long term insulin pump use for people with type 1 diabetes. We use a first-of-its-kind method to successfully delivery a therapeutic, such as insulin, into subcutaneous tissue and past any blockage that can occur from the foreign body response.”

Greta Preatoni (CH): MY-SENSATION – Reducing pain and restoring touch in diabetic neuropathy through a fully wearable non-invasive neuromodulation system

“We developed a unique wearable device that restores the sense of touch and decreases pain through a non-invasive electrical nerve stimulation driven by AI algorithms. Thanks to years of research, we achieved a carefully designed electrode placement and optimal stimulation parameters, that can target directly the nerves with a pleasant stimulation, hence reducing neuropathic pain by more than 40% after just one use.”

Roman Sojic (CH): Fastskin®, a revolutionary treatment for chronic wounds

“FastSkin® is a new autologous treatment for chronic wounds. It combines micrografting and blood clotting, enhanced by sonication, to accelerate healing and address the unmet clinical need in chronic wound management, including diabetic wounds. Micrografting stimulates cellular growth, kickstarting the restoration of damaged tissue and speeding up wound closure.”

Elvis Silva (BR): SmartWalk® Plus: it is time to stay in range!

“SmartWalk® us a device capable of generating the mechanical pattern of walking, but at 1,680 steps/minute. Using the resonant frequencies of muscle fibers, it may induce the translocation of glucose transporters (GLUT4) to the cell membrane and the release of undercarboxylated osteocalcin through bone remodeling. Simply put: SmartWalk® may reduce postprandial glucose spikes and also prevent hypoglycemia.”

Rohan Arora (IN): Diaplay – Learning diabetes management by playing games!

“For a newly diagnosed, every few days diabetes can throw new questions for which they try to find answers through whichever means available. The current learning process to understand diabetes can be boring, intimidating or challenging and seems like added burden. We are trying to develop gaming devices which will help people living with diabetes to learn, understand, have conversations and inculcate good habits to manage diabetes in a fun & interactive way.”

Deval Karia (IN): InsuFlo – An affordable insulin pump for people with diabetes

“Adoption of CSII is sparse, particularly in resource constrained settings like India. Institutional factors aside, fixed, and recurring costs of such a device are often found to be a withholding factor to widespread adoption. This is the exact problem we have attempted to address: making an affordable insulin pump (InsuFlo) that is accessible to patients at the base of the economic pyramid. The other problem that we’ve attempted to address is the design of a pump particularly catering to Indian patients.”